Open AccessThe diagnostic value of tumor markers in bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma
Author(s) -
Zhang Shi,
Zhao Yunfeng,
Zhang Mingzhou,
Wu Xueling
Publication year - 2017
Publication title -
the clinical respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 33
eISSN - 1752-699X
pISSN - 1752-6981
DOI - 10.1111/crj.12362
Subject(s) - medicine , bronchoalveolar lavage , enolase , lung cancer , pathology , carcinoembryonic antigen , lung , cytokeratin , gastroenterology , cancer , immunohistochemistry
Background To investigate the value of Ubiquitin specific peptidase 8 (USP8), Chitinase 3‐like 1 (YKL40), Heat shock protein 90a (HSP90α), glutathione S‐transferase P1 (GSTP1), carcinoembryonic antigen (CEA), neuron specific enolase (NSE) and cytokeratin fragment antiogen 21‐1 (CYFRA21‐1) in bronchoalveolar lavage fluid (BALF) and serum for diagnosis in patients with peripheral lung cancer. Methods The concentration of these markers were measured in 50 patients with peripheral lung cancer and 50 patients with benign lung diseases by using enzyme‐linked immuno sorbent assay methods. Results There were significant differences between the peripheral lung cancer group and the benign lung disease group ( P < 0.05) in the BALF of USP8, YKL40, HSP90α, CEA, NSE and CYFRA21‐1. There were significant differences between the peripheral lung cancer group and the benign lung disease group ( P < 0.05) in the serum of HSP90α and CEA. There were no differences in others. There were no correlation between the concentration of all markers and age, histological type, TNM stage (I–IV). There was a weak correlation between the primary foci diameters and the concentration of YKL40 in BALF. (Pearson's correlation: 0.203, P = 0.048) The diagnostic efficiencies of USP8, YKL40, HSP90α were superior to CYFRA21‐1 and NSE, being lower CEA. Conclusion: Detection of tumor markers in BALF was superior to serum specimens. The measurement of USP8, HSP90α and YKL40 in BALF had more clinical value for the diagnosis of peripheral pulmonary carcinoma.